Cellectis Inc.

Contributing Author

Recent Articles by Cellectis Inc.

Nov-03	Cellectis to Present a Development Update for eti-cel at ASH 2025 CLLS -5.22% GlobeNewswire
Oct-31	Cellectis to Report Third Quarter Financial Results on November 7, 2025 CLLS GlobeNewswire
Oct-16	Cellectis' R&D Day Highlights Lasme-cel's Potential to Address Significant Unmet Need for Patients with r/r B-ALL CLLS GlobeNewswire
Oct-16	Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers CLLS GlobeNewswire
Oct-07	Monthly information on share capital and company voting rights CLLS GlobeNewswire
Oct-07	Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress CLLS GlobeNewswire
Sep-03	Monthly information on share capital and company voting rights CLLS GlobeNewswire
Aug-07	Monthly information on share capital and company voting rights CLLS GlobeNewswire
Aug-04	Cellectis Reports Second Quarter 2025 Financial Results & Business Updates CLLS GlobeNewswire
Jul-28	Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025 CLLS GlobeNewswire
Jul-04	Monthly information on share capital and company voting rights CLLS GlobeNewswire
Jun-26	Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025 CLLS GlobeNewswire
Jun-05	Monthly information on share capital and company voting rights CLLS GlobeNewswire
May-21	Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 CLLS GlobeNewswire
May-12	Cellectis Reports Financial Results for the First Quarter 2025 CLLS GlobeNewswire
May-07	Monthly information on share capital and company voting rights CLLS GlobeNewswire
May-06	Cellectis to Report First Quarter Financial Results on May 12, 2025 CLLS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.